FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for clopidogrel bisulfate by Sun Pharmaceutical Industries, Inc. The approval covers the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction
• Peripheral Artery Disease
• Stroke

Drugs mentioned

• Clopidogrel bisulfate (clopidogrel bisulfate)

Snippet

SUPPL AP for CLOPIDOGREL BISULFATE (CLOPIDOGREL BISULFATE)